Processing

Please wait...

Settings

Settings

Goto Application

1. WO2002004505 - A NOVEL POLYPEPTIDE - HUMAN SEMAPHORIN PROTEIN 9 AND A POLYNUCLEOTIDE ENCODING THE SAME

Publication Number WO/2002/004505
Publication Date 17.01.2002
International Application No. PCT/CN2001/000995
International Filing Date 18.06.2001
IPC
C07K 14/47 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435from animals; from humans
46from vertebrates
47from mammals
CPC
C07K 14/4703
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435from animals; from humans
46from vertebrates
47from mammals
4701not used
4702Regulators; Modulating activity
4703Inhibitors; Suppressors
Applicants
  • BIOWINDOW GENE DEVELOPMENT INC. SHANGHAI [CN]/[CN] (AllExceptUS)
  • MAO, Yumin [CN]/[CN] (UsOnly)
  • XIE, Yi [CN]/[CN] (UsOnly)
Inventors
  • MAO, Yumin
  • XIE, Yi
Agents
  • WATSON & BAND LAW OFFICES
Priority Data
00 1 16602.619.06.2000CN
Publication Language Chinese (zh)
Filing Language Chinese (ZH)
Designated States
Title
(EN) A NOVEL POLYPEPTIDE - HUMAN SEMAPHORIN PROTEIN 9 AND A POLYNUCLEOTIDE ENCODING THE SAME
(FR) NOUVEAU POLYPEPTIDE, SEMAPHORINE HUMAINE 9, ET POLYNUCLEOTIDE CODANT CE POLYPEPTIDE
Abstract
(EN) The present invention discloses a novel polypeptide human semaphorin protein 9 and a polynucleotide encoding the same, as well as a method of producing the polypeptide by DNA recombinant technique. The present invention also discloses methods of using the polypeptide in treatment of various disease, such as nerve system deforming, disease associated with functional disturbance of nerve system and so on. The present invention also discloses an antagonist agains the polypeptide and the therapeutic use of the same. The present invention also discloses the use of such polynucleotide encoding human semaphorin protein 9.
(FR) L'invention concerne un nouveau polypeptide, une sémaphorine humaine 9, et un polynucléotide codant ce polypeptide ainsi qu'un procédé d'obtention de ce polypeptide par des techniques recombinantes d'ADN. L'invention concerne en outre les applications de ce polypeptide dans le traitement de maladies, notamment de malformations du système nerveux et de maladies liées au dysfonctionnement du système nerveux. L'invention concerne aussi l'antagoniste agissant contre le polypeptide et son action thérapeutique ainsi que les applications de ce polynucléotide codant la sémaphorine humaine 9.
Related patent documents
Latest bibliographic data on file with the International Bureau